The ABCs of ADCs: Why antibody-drug conjugates are so hot right now
Podcast: BioSpacePublished On: Wed Mar 06 2024
Description: These days you can hardly move without figuratively bumping into antibody-drug conjugates (ADCs). This week we discuss Pfizer's strategic priorities for oncology - focused on ADCs and less on small molecules - and how the market is being influenced by the IRA.
The note was deleted
The note was saved
Your message was sent